Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in City of Hewitt: The Definitive Guide for Women, Families, and Survivors

If you are a woman in City of Hewitt who underwent breast reconstruction following a mastectomy, a breast lift (mastopexy), or a cosmetic augmentation, you likely believed the medical devices used in your body were specifically designed and rigorously tested for the breast. For many patients in City of Hewitt and throughout McLennan County, the reality is far more concerning. Many of the products currently used in these procedures—including acellular dermal matrix (ADM) and bioabsorbable scaffolds like GalaFLEX—have never been formally cleared or approved by the FDA for use in breast surgery.

At Attorney911, led by Ralph Manginello and Lupe Peña, we represent women who are now facing the devastating consequences of these defective devices. If you are dealing with chronic infection, reconstruction failure, skin necrosis, or a diagnosis of breast implant-associated cancer, you are not alone. Our firm brings twenty-seven years of continuous litigation experience and a deep command of federal medical device regulation to every case we handle for Hewitt families. We invite you to examine this resource to understand the science, the law, and the path to justice for City of Hewitt survivors.

Understanding the “Internal Bra” and the Devices Used in City of Hewitt Surgeries

In recent years, surgeons in City of Hewitt and the greater Waco medical community have increasingly utilized what is marketed as the “internal bra” technique. This method uses a biological or synthetic material to create a hammock-like structure that supports the lower pole of a breast implant or tissue expander. While the concept sounds promising for long-term aesthetic results, the materials used frequently trigger severe immunological or infectious responses.

We categorize these devices into three primary groups:

1. Acellular Dermal Matrix (ADM): These are biological grafts derived from human cadaver skin (like AlloDerm or FlexHD) or porcine (pig) skin (like Strattice). The manufacturer removes the cells to leave behind a collagen scaffold, intended to integrate with your own tissue. However, if this material is contaminated with bacterial endotoxins, it can lead to “Red Breast Syndrome,” a sterile but severe inflammatory reaction often seen in patients from City of Hewitt.
2. Bioabsorbable Scaffolds: These are synthetic meshes, most notably GalaFLEX and Phasix, made from a plastic called poly-4-hydroxybutyrate (P4HB). They are designed to stay in your body for 18 to 24 months before dissolving. Frequently, however, these products fail to resorb on time or lead to chronic pain and palpable mesh edges that Hewitt women must then have surgically removed.
3. Synthetic Mesh: In some cases, traditional polypropylene meshes designed for hernia repair are used off-label in the breast. These permanent synthetics are often incompatible with delicate breast tissue, leading to erosion and chronic infection.

Ralph Manginello and the team at Attorney911 emphasize that the FDA’s November 9, 2023, letter to healthcare providers made the situation clear: the safety and effectiveness of these surgical meshes in breast surgery have not been determined. For many women in City of Hewitt, this was the first time they realized their “internal bra” was an experimental application of a device cleared for a different purpose.

The FDA Regulatory Timeline and the 2023 Warning to City of Hewitt Patients

The regulatory history of these devices is a story of “predicate creep.” Most of these products entered the market through the FDA 510(k) clearance pathway. Under 21 USC §360c and 21 CFR Part 807, a manufacturer only has to show that their device is “substantially equivalent” to an older device. They do not have to prove the device is safe or effective for a new use like breast reconstruction.

This regulatory loophole has left Hewitt patients vulnerable. At Attorney911, we track the specific failures of the system:

• September 2022: The FDA issued a safety communication regarding Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC), a rare but deadly cancer found in the scar tissue capsule.
• March 2021: The FDA warned that acellular dermal matrices like FlexHD and AlloMax were associated with significantly higher rates of infection and explantation.
• November 2023: The FDA formally notified surgeons that products like GalaFLEX, GalaFLEX 3D, and Phasix were not studied or cleared for breast reconstruction.

If you received one of these devices in City of Hewitt, your surgeon had a duty under the learned intermediary doctrine to warn you of these specific risks. However, if the manufacturer, such as Becton Dickinson (BD) or Allergan/AbbVie, engaged in misleading off-label promotion, they may be held strictly liable for your injuries. Lupe Peña, who brings a unique perspective from his background in insurance defense, knows how manufacturers attempt to hide behind these regulatory clearances. We use that insider knowledge to fight for your recovery.

If you are suffering, call 1-888-ATTY-911 for a free, confidential consultation. Ralph Manginello and Lupe Peña are ready to help the City of Hewitt community.

The Complication Spectrum: What Hewitt Survivors Are Facing

Complications from defective mesh or ADM are rarely “minor.” For a resident of City of Hewitt, a complication often means multiple unplanned trips to the operating room and months of IV antibiotics. Our firm represents women across the full spectrum of these injuries:

• Skin-Flap and Nipple Necrosis: When the mesh or ADM compromises blood flow, the skin overlying the breast can die. This is a catastrophic outcome in any Hewitt reconstruction case, often requiring the total abandonment of the reconstruction.
• Red Breast Syndrome (RBS): This is a non-infectious, sterile inflammation specific to ADM products. It is caused by bacterial endotoxins—lipopolysaccharides—that remain on the graft even after sterilization.
• Capsular Contracture: While common with implants, the addition of mesh or ADM can accelerate the hardening of the scar tissue (Baker Grade III/IV), causing the breast to become rock-hard and painfully misshapen.
• Scaffold Failure and Ptosis: If a bioabsorbable scaffold like GalaFLEX dissolves too early, the breast may “bottom out,” losing the very support the patient in City of Hewitt paid for.

The psychological impact on the Hewitt community cannot be overstated. Research indicates that approximately 32% of cancer survivors suffer from significant psychiatric distress, and this number skyrockets when a reconstruction fails. Ralph Manginello ensures that our damage models for Hewitt clients include not just the medical bills, but the profound pain, suffering, and loss of quality of life.

Breast Implant-Associated Lymphoma (BIA-ALCL) and Carcinoma (BIA-SCC)

Perhaps the most frightening complication for women in City of Hewitt is the link between textured devices and cancer. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a distinct T-cell lymphoma (CD30 positive, ALK negative). Federal records show that textured surfaces, like those found on the recalled Allergan BIOCELL implants, are six times more likely to cause this malignancy.

Furthermore, the emerging literature on BIA-SCC (Squamous Cell Carcinoma) shows that these epithelial tumors can develop 7 to 42 years post-implantation. For the patient in City of Hewitt who received her implants in the 1990s or 2000s, a new lump or asymmetric swelling today demands immediate investigation.

Lupe Peña and Ralph Manginello are admitted to the United States District Court for the Southern District of Texas and are equipped to handle these complex oncological claims. We understand the pathology, the immunohistochemistry, and the necessity of preserving the explanted device and the capsule tissue as Tier 1 evidence for your City of Hewitt lawsuit.

Legal Theories for Justice in McLennan County: Why the Manufacturer is Liable

Your case in City of Hewitt is likely grounded in three primary legal theories:

1. Failure to Warn: The manufacturer knew about the elevated infection rates of ADM or the cancer risks of textured surfaces but failed to provide Hewitt surgeons with adequate warnings.
2. Design Defect: Using a resorbable plastic like P4HB (GalaFLEX) in the breast is inherently dangerous because of the way the material hydrolyzes and triggers inflammation in the proximity of breast tissue.
3. Off-Label Promotion: Manufacturers frequently trained sales representatives to encourage Hewitt surgeons to use these devices in the breast, despite knowing they lacked FDA clearance for that specific indication.

In Texas, we operate under a strict product liability framework. Ralph P. Manginello, who has been licensed since 1998 under Bar Card 24007597, understands how to navigate the Riegel v. Medtronic preemption defense. Because these devices were cleared through 510(k) and not the more stringent Premarket Approval (PMA) process, your right to sue for state-law negligence in City of Hewitt remains largely intact.

Whistleblower Evidence: The Case Against Becton Dickinson (BD)

One of the most critical elements of current breast mesh litigation involves the whistleblower record of Dr. Hooman Noorchashm. A former Medical Director at Becton Dickinson, Dr. Noorchashm was terminated in 2022 after raising safety concerns about GalaFLEX and Phasix. He alleged that BD withheld data regarding breast cancer recurrences in their clinical trials and failed to report adverse events to the FDA’s MAUDE database.

For a woman in City of Hewitt, this evidence is a “game-changer.” It suggests that the complications you suffered weren’t just “unfortunate risks”—they were foreseeable events that the manufacturer allegedly concealed from the public. At Attorney911, we integrate this high-level investigative data into every Hewitt case to prove corporate negligence.

The Manginello Law Firm: Twenty-Seven Years of Aggressive Advocacy for City of Hewitt

Choosing the right lawyer in City of Hewitt is a decision that affects your financial and medical future. Ralph Manginello is a Houston native who has spent nearly three decades fighting institutional defendants. Our firm is currently lead counsel in high-profile litigation like Bermudez v. Pi Kappa Phi, where we are seeking $10 million in damages for institutional liability. This is the level of litigation power we bring to defective device cases for City of Hewitt survivors.

Our firm holds an 8.2 “Excellent” rating on Avvo and has hundreds of 4.9-star reviews across Birdeye and Google. We are members of the Pro Bono College of the State Bar of Texas, reflecting our commitment to service and integrity. When you call 1-888-ATTY-911, you aren’t getting a call center; you are getting a team that knows Hewitt, knows McLennan County, and knows how to win.

Hablamos Español: Lupe Peña and Language Access in City of Hewitt

Access to justice should not be gated by language. City of Hewitt has a significant Spanish-speaking population that may not have received adequate informed consent in their native language before surgery. Lupe Peña conducts full client consultations in fluent Spanish, ensuring that our Hewitt clients understand every aspect of their case without the need for an interpreter.

Si usted o un ser querido en City of Hewitt ha sufrido lesiones debido a una malla mamaria defectuosa, llame a Lupe Peña al 1-888-ATTY-911. Estamos aquí para luchar por usted.

Practical Steps for City of Hewitt Patients: Preserving Your Evidence

If you suspect your “internal bra” or ADM is failing in City of Hewitt, you must act strategically to preserve your legal rights:

1. Request Your Operative Report: Every hospital in the Hewitt and Waco area is required to maintain these records. Look for “stickers” or “lot numbers” for the mesh, ADM, or scaffold used.
2. Document Symptoms: Take photographs of any redness, drainage, or asymmetry. Keep a daily journal of your pain levels.
3. Preserve the Device: If you undergo revision surgery in City of Hewitt, instruct your surgeon and the pathology lab that any explanted mesh or tissue capsule must be preserved for your legal team—do not let the hospital discard it.
4. Confirm Your Brand: Identifying if you have AlloDerm, FlexHD, GalaFLEX, or Phasix is the first step in connecting your case to the ongoing national litigation.

The statute of limitations in Texas is generally two years from the date of injury or the date of discovery. For many women in City of Hewitt, the “clock” may have started when the FDA issued its 2023 warning. Do not wait until it is too late to protect your family’s future.

Frequently Asked Questions for Hewitt Residents

Is surgical mesh actually approved by the FDA for breast surgery?
No. As of today, the FDA has not cleared or approved any surgical mesh for use in breast reconstruction or augmentation. They are used “off-label” in City of Hewitt.

What if my surgery was years ago? Can I still sue?
Yes. Under the discovery rule in Texas, the statute of limitations may not begin until you realized (or should have realized) that the device caused your injury. Many Hewitt patients are only now discovering the link thanks to new FDA communications.

How much does a breast mesh lawyer cost in City of Hewitt?
At Attorney911, we work on a contingency fee basis. This means there is no upfront cost to you. We only get paid if we recover a settlement or verdict for you. We take the financial risk so you can focus on healing in Hewitt.

Can I sue the hospital or my surgeon in City of Hewitt?
In some cases, yes. If the surgeon failed to disclose that the device was off-label or if the hospital was negligent in its credentialing and product selection, they may be named alongside the manufacturer.

What is the “whistleblower” case everyone is talking about?
Dr. Hooman Noorchashm has provided evidence that manufacturers like BD knew about GalaFLEX risks but withheld them. This evidence is central to proving that the manufacturer prioritized profits over the safety of Hewitt women.

Resources and Support for Survivors in City of Hewitt

If you are a breast cancer survivor in City of Hewitt dealing with reconstruction failure, we recommend connecting with independent support networks that are not funded by device manufacturers:

• FORCE (Facing Our Risk of Cancer Empowered): An excellent resource for Hewitt BRCA1/2 mutation carriers.
• The Pink Fund: Provides financial assistance for Hewitt patients in active treatment.
• BIA-ALCL Support Groups: Specialized networks for women facing textured-implant concerns.
• SHARE Cancer Support: Offers bilingual patient navigation and support for City of Hewitt families.

Contact Attorney911 for a Free Case Evaluation in City of Hewitt

You did not choose to be part of a medical experiment. You chose reconstruction or augmentation to feel whole again after cancer or to gain confidence. When manufacturers like Allergan, BD, or Integra LifeSciences bypass safety protocols, they owe the City of Hewitt community more than just an apology—they owe you compensation for everything you have lost.

Ralph Manginello and Lupe Peña are ready to hear your story. Whether you are at a hospital in Waco, resting at home in City of Hewitt, or seeking a second opinion, we are available to talk. We have the technical expertise, the 27-year record of litigation, and the local Hewitt roots to take on the world’s largest device makers.

Call us today at 1-888-ATTY-911 (1-888-288-9911) or visit our website to schedule your free consultation. We serve City of Hewitt, McLennan County, and all of Texas with the aggressive advocacy you deserve.

Note: Past results do not guarantee future outcomes. This content is for educational purposes and does not constitute legal advice. No attorney-client relationship is formed until a written agreement is signed.

The Manginello Law Firm, PLLC
1177 West Loop South, Suite 1600
Houston, Texas 77027
1-888-ATTY-911